The Importance of Dysbiosis in the Upper GI Tract
The term “dysbiosis” denotes imbalances or disruptions in the microbiome that are thought to contribute to a long and growing list of chronic diseases and conditions. To date, microbiome research has largely focused on dysbiosis in the colon, which is typically assessed via stool sampling.
Recent research indicates that the oral microbiome may also be involved in certain disease processes. Dysbiosis in other areas of the gastrointestinal tract has been less extensively explored, but emerging evidence indicates that dysbiosis in these areas may also have important impacts on health.
In this presentation, we will explore what’s known about dysbiosis in the upper GI tract (especially in the stomach and upper small intestine), and how advanced DNA-based stool testing may provide important clinical insights.
Author Tom Fabian, Ph.D., CNTP
Dr. Fabian is a leading expert on the role of the microbiome in health, immune function, chronic disease, and aging. As a translational scientist, his primary focus is on the clinical application of microbiome research in the integrative and functional medicine space. He received his PhD in molecular biology from the University of Colorado, Boulder, and has worked as a biomedical researcher in the biotechnology industry...
The opinions expressed in this presentation are the author's own. Information is provided for informational purposes only and is not meant to be a substitute for personal advice provided by a doctor or other qualified health care professional. Patients should not use the information contained herein for diagnosing a health or fitness problem or disease. Patients should always consult with a doctor or other health care professional for medical advice or information about diagnosis and treatment.